Suppr超能文献

在人工制备的干血斑和口腔液中进行严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抗体检测的微球免疫测定的实验室间协调。

Inter-laboratory harmonization of microsphere immunoassays for SARS-CoV-2 antibody detection in contrived dried blood spots and oral fluids.

作者信息

DeRosa Kate L, Pisanic Nora, Kruczynski Kate, Heaney Christopher D, Styer Linda M, Mantis Nicholas J

机构信息

New York State Department of Health, Wadsworth Center, Albany, New York, USA.

Department of Environmental Health and Engineering, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.

出版信息

Microbiol Spectr. 2025 Mar 25;13(5):e0269024. doi: 10.1128/spectrum.02690-24.

Abstract

UNLABELLED

Dried blood spots (DBS) and oral fluids (OF) are easily attainable biospecimen types that enabled population-scale antibody monitoring for SARS-CoV-2 exposure and vaccination. However, the degree to which the two different biospecimen types can be used interchangeably remains unclear. To address this question, we generated contrived DBS (cDBS) and contrived OF (cOF) from serum panels of SARS-CoV-2-infected, vaccinated, and uninfected individuals. The contrived samples were evaluated using SARS-CoV-2 multiplexed microsphere immunoassays (MIAs) at two different institutions. Intra-laboratory tests revealed near-perfect agreement between cDBS and cOF for N and S antigens, as evidenced by κ = 0.97-1 and 98%-100% agreement. Interlaboratory comparisons were equally robust for both N (κ = 0.94-0.96; 97.5%-98 % agreement) and S (κ = 0.98-1.0; 99.0%-100%). Furthermore, assays were transferred between labs, including methods and reagents, and a subset of cDBS and cOF samples ( = 52) were tested. Qualitative concordance remained high (κ = 0.94-1.0; 97.5%-100% agreement), confirming that the integrity of the assays is retained upon transfer. In summary, our results provide evidence that DBS and OF can be used interchangeably across laboratories and institutions for the qualitative assessment of SARS-CoV-2 antibody determinations.

IMPORTANCE

The establishment of common research and clinical laboratory methodologies for the assessment of SARS-CoV-2 antibody levels in different biospecimen types is of paramount importance in estimating immunity to COVID-19 infections in communities and populations. In this report, we evaluated multiplex immunoassay protocols to enable comparisons between two readily attainable biospecimen types, namely, dried blood spots (DBS) and oral fluids (OF), which are employed in population-scale antibody monitoring of SARS-CoV-2 antibody titers and virus-neutralizing potential.

摘要

未标注

干血斑(DBS)和口腔液(OF)是易于获取的生物样本类型,可用于对SARS-CoV-2暴露和疫苗接种情况进行人群规模的抗体监测。然而,这两种不同生物样本类型可互换使用的程度仍不明确。为解决这个问题,我们从感染SARS-CoV-2、接种疫苗和未感染的个体血清样本中制备了人工干血斑(cDBS)和人工口腔液(cOF)。在两个不同机构使用SARS-CoV-2多重微球免疫测定(MIA)对这些人工样本进行了评估。实验室内测试显示,cDBS和cOF在N和S抗原方面的一致性近乎完美,κ值为0.97 - 1,一致性为98% - 100%。实验室间比较对于N(κ = 0.94 - 0.96;一致性为97.5% - 98%)和S(κ = 0.98 - 1.0;一致性为99.0% - 100%)同样可靠。此外,检测方法和试剂在不同实验室之间进行了转移,并对一部分cDBS和cOF样本(n = 52)进行了测试。定性一致性仍然很高(κ = 0.94 - 1.0;一致性为97.5% - 100%),证实检测方法在转移后仍保持完整性。总之,我们的结果表明,DBS和OF可在不同实验室和机构之间互换使用,用于SARS-CoV-2抗体测定的定性评估。

重要性

建立用于评估不同生物样本类型中SARS-CoV-2抗体水平的通用研究和临床实验室方法,对于估计社区和人群对COVID-19感染的免疫力至关重要。在本报告中,我们评估了多重免疫测定方案,以便能够在两种易于获取的生物样本类型,即干血斑(DBS)和口腔液(OF)之间进行比较,这两种样本类型用于SARS-CoV-2抗体滴度和病毒中和潜力的人群规模抗体监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1c9/12054174/537a9fc9207d/spectrum.02690-24.f001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验